Sens. McCain, Schumer Sponsor Generic Drug Approval Acceleration Bill
This article was originally published in The Tan Sheet
Executive Summary
Sens. John McCain (R-Ariz.) and Charles Schumer (D-N.Y.) intend to rally support in the next session of Congress for legislation introduced Sept. 14 that would ease the FDA approval process for generic drugs.
You may also be interested in...
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.